Efficacy of customized corneal crosslinking versus standard corneal crosslinking in patients with progressive keratoconus (C-CROSS study): study protocol for a randomized controlled trial

Abstract Background Keratoconus is a degenerative disorder of the cornea leading to a protrusion and thinning with loss of visual acuity. The only treatment to halt the progression is corneal crosslinking (CXL), which uses riboflavin and UV-A light to stiffen the cornea. Recent ultra-structural exam...

Full description

Bibliographic Details
Main Authors: Magali M. S. Vandevenne, Tos T. J. M. Berendschot, Bjorn Winkens, Frank J. H. M. van den Biggelaar, Nienke Visser, Mor M. Dickman, Robert P. L. Wisse, Robert-Jan H. J. Wijdh, Abhijit Sinha Roy, Rohit Shetty, Rudy M. M. A. Nuijts
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-023-02976-4